betamethasone valerate 1.2 MG/ML Topical Foam [Luxiq]

RxNorm concept 1244636, branded drug (sbd). Prescribable name: Luxiq 0.12 % Topical Foam.

RxCUI: 1244636
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/1244636 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

betamethasone 1514

Other names

Luxiq 0.12 % Topical Foam; Luxiq 1.2 MG/ML Topical Foam

Related concepts

betamethasone valerate 1.2 MG/ML (SCDC, consists of)
betamethasone valerate 1.2 MG/ML [Luxiq] (SBDC, consists of)
Topical Foam (DF, has dose form)
Luxiq (BN, has ingredient)
betamethasone valerate 1.2 MG/ML Topical Foam (SCD, tradename of)

Linked data

NDCs

00378818701
00378818750

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 1244636 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/1244636 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 1244636. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.